YAP1 and cancer: In cancer however, reduced phosphorylation of YAP/TAZ allows for their translocation to the nucleus and activation of oncogenic and metastatic pathways, including TGF-β/SMAD, WNT/β-Catenin and ILK signaling21, 22, 23.